Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0SB5H
|
|||
| Former ID |
DNC005149
|
|||
| Drug Name |
2-Methyl-[1,4]thiazepan-(5E)-ylideneamine
|
|||
| Synonyms |
CHEMBL187008; 2-Methyl-[1,4]thiazepan-(5E)-ylideneamine; BDBM50155783
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C6H12N2S
|
|||
| Canonical SMILES |
CC1CN=C(CCS1)N
|
|||
| InChI |
1S/C6H12N2S/c1-5-4-8-6(7)2-3-9-5/h5H,2-4H2,1H3,(H2,7,8)
|
|||
| InChIKey |
FACIWFABQIDLEA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis of analogs of (1,4)-3- and 5-imino oxazepane, thiazepane, and diazepane as inhibitors of nitric oxide synthases. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5907-11. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.